FDA Advisory Committee Votes Unanimously to Support the Use of Teprotumumab for the Treatment of Thyroid Eye Disease (TED)

DUBLIN--(BUSINESS WIRE)--Horizon today announced the outcome of the FDA Advisory Committee meeting for teprotumumab for the treatment of thyroid eye disease (TED).

Full Story →